Convegni & Meeting

Tissue Factor Pathway Inhibitor 2 (TFPI2) methylated DNA is a sensitive and specific serum biomarker of metastatic melanoma

Posted on 17 dicembre 2014

Lo Nigro C, Wang H, Lattanzio L, Matin R, Harwood C, Syed N, Occelli M, Merlano M, Evans A, Thompson A, Leigh I, Fleming C, Proby C, Crook T: “Tissue Factor Pathway Inhibitor 2 (TFPI2) methylated DNA is a sensitive and specific serum biomarker of metastatic melanoma”, XVIII Annual Meeting of IMI (Italian Melanoma Intergroup), […]

A friendly, cheap and very sensitive method for k-Ras point mutations detection based on PNA-directed PCR-clamping in metastatic colorectal carcinoma

Posted on 17 dicembre 2014

Messa F, Bracco E, Millo E, Tornissi F, Ungari S, Lattanzio L, Merlano M, Damonte G, Lo Nigro C: “A friendly, cheap and very sensitive method for k-Ras point mutations detection based on PNA-directed PCR-clamping in metastatic colorectal carcinoma”, 54 Congresso Nazionale della Società Italiana di Cancerologia (SIC), Bologna, 1-4 ottobre 2012.

Differential molecular mechanism of the docetaxel-octreotide combined treatment according to the docetaxel-resistance status in PC3 prostate cancer cells

Posted on 17 dicembre 2014

Lattanzio L, Tonissi F, Monteverde M, Milano G, Merlano M, Lo Nigro C: “Differential molecular mechanism of the docetaxel-octreotide combined treatment according to the docetaxel-resistance status in PC3 prostate cancer cells”, 54 Congresso Nazionale della Società Italiana di Cancerologia (SIC), Bologna, 1-4 ottobre 2012.

A demethylation screen identifies zinc finger protein 655/Vav-interacting kinase (Vik-1) as a novel putative tumour suppressor gene in lung cancer

Posted on 17 dicembre 2014

O’Leary K, Cavicchioli F, Shia A, Haley V, Comino A, Wischnewsky MB, Crook T, Lo Nigro C, Schmid P: “A demethylation screen identifies zinc finger protein 655/Vav-interacting kinase (Vik-1) as a novel putative tumour suppressor gene in lung cancer”, The European Association for Cancer Research (EACR-22), Barcellona, 7-10 luglio 2012.

Antibody-dependent cell-mediated cytotoxicity (ADCC) evolution under treatment by cetuximab and links with treatment outcome in colorectal cancer (CRC) patients

Posted on 17 dicembre 2014

Merlano M, Monteverde M, Strola G, Barriere J, Etienne-Grimaldi MC, Miraglio E, Lattanzio L, Vivenza  D, Messa F, Lo Nigro C, Milano G: “Antibody-dependent cell-mediated cytotoxicity (ADCC) evolution under treatment by cetuximab and links with treatment outcome in colorectal cancer (CRC) patients”, ASCO Annual Meeting, Chicago, 1-5 giugno 2012.

Allelic distribution of aldosteron-syntase receptor in a congestive heart failure Caucasian population

Posted on 17 dicembre 2014

Feola M, Mussapi F, Crosetto N, Vivenza D, Lo Nigro C, Vado A: “Allelic distribution of aldosteron-syntase receptor in a congestive heart failure Caucasian population”, Heart Failure Congress 2012, Belgrado, Germania, 19-22 maggio 2012.